For example, the single nucleotide polymorphism (c.521T > C, p.Val174Ala) in the SLCO1B1 gene reduces the transport capacity of OATP1B1, leading to elevated plasma levels of simvastatin acid and elevating the risk of simvastatin-induced myopathy [17,35]. Here, SLCO1B1 is linked to myopathy.